These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 15526351

  • 1. The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system.
    Bjørnerud A, Johansson L.
    NMR Biomed; 2004 Nov; 17(7):465-77. PubMed ID: 15526351
    [Abstract] [Full Text] [Related]

  • 2. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging.
    Stoll G, Bendszus M.
    Neuroscience; 2009 Feb 06; 158(3):1151-60. PubMed ID: 18651996
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance relaxation properties of superparamagnetic particles.
    Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009 Feb 06; 1(3):299-310. PubMed ID: 20049798
    [Abstract] [Full Text] [Related]

  • 4. Applications of ultrasmall superparamagnetic iron oxide contrast agents in the MR study of animal models.
    Wu EX, Tang H, Jensen JH.
    NMR Biomed; 2004 Nov 06; 17(7):478-83. PubMed ID: 15526349
    [Abstract] [Full Text] [Related]

  • 5. Contrast agents: magnetic resonance.
    Burtea C, Laurent S, Vander Elst L, Muller RN.
    Handb Exp Pharmacol; 2008 Nov 06; (185 Pt 1):135-65. PubMed ID: 18626802
    [Abstract] [Full Text] [Related]

  • 6. Iron oxide MR contrast agents for molecular and cellular imaging.
    Bulte JW, Kraitchman DL.
    NMR Biomed; 2004 Nov 06; 17(7):484-99. PubMed ID: 15526347
    [Abstract] [Full Text] [Related]

  • 7. Magnetic iron oxide nanoparticles for biomedical applications.
    Laurent S, Bridot JL, Elst LV, Muller RN.
    Future Med Chem; 2010 Mar 06; 2(3):427-49. PubMed ID: 21426176
    [Abstract] [Full Text] [Related]

  • 8. Molecular imaging with targeted contrast agents.
    Makowski MR, Wiethoff AJ, Jansen CH, Botnar RM.
    Top Magn Reson Imaging; 2009 Aug 06; 20(4):247-59. PubMed ID: 20805735
    [Abstract] [Full Text] [Related]

  • 9. Nanotechnology and MRI contrast enhancement.
    Matson ML, Wilson LJ.
    Future Med Chem; 2010 Mar 06; 2(3):491-502. PubMed ID: 21426177
    [Abstract] [Full Text] [Related]

  • 10. High-resolution MR imaging of mouse brain microvasculature using the relaxation rate shift index Q.
    Wu EX, Tang H, Jensen JH.
    NMR Biomed; 2004 Nov 06; 17(7):507-12. PubMed ID: 15523704
    [Abstract] [Full Text] [Related]

  • 11. Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy.
    Smirnov P.
    Methods Mol Biol; 2009 Nov 06; 512():333-53. PubMed ID: 19347287
    [Abstract] [Full Text] [Related]

  • 12. MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles.
    Martin AR, Thompson RB, Finlay WH.
    J Aerosol Med Pulm Drug Deliv; 2008 Dec 06; 21(4):335-42. PubMed ID: 18800881
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
    Gupta AK, Gupta M.
    Biomaterials; 2005 Jun 06; 26(18):3995-4021. PubMed ID: 15626447
    [Abstract] [Full Text] [Related]

  • 14. Molecular magnetic resonance imaging with targeted contrast agents.
    Artemov D.
    J Cell Biochem; 2003 Oct 15; 90(3):518-24. PubMed ID: 14523986
    [Abstract] [Full Text] [Related]

  • 15. Usage of the T1 effect of an iron oxide contrast agent in an animal model to quantify myocardial blood flow by MRI.
    Lüdemann L, Schmitt B, Podrabsky P, Schnackenburg B, Böck J, Gutberlet M.
    Eur J Radiol; 2007 May 15; 62(2):247-56. PubMed ID: 17188443
    [Abstract] [Full Text] [Related]

  • 16. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
    Taboada E, Rodríguez E, Roig A, Oró J, Roch A, Muller RN.
    Langmuir; 2007 Apr 10; 23(8):4583-8. PubMed ID: 17355158
    [Abstract] [Full Text] [Related]

  • 17. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
    Lin JJ, Chen JS, Huang SJ, Ko JH, Wang YM, Chen TL, Wang LF.
    Biomaterials; 2009 Oct 10; 30(28):5114-24. PubMed ID: 19560199
    [Abstract] [Full Text] [Related]

  • 18. Iron-fortified MRI: effects and applications of iron-induced NMR relaxation in biological tissues.
    Jensen JH, Helpern JA.
    NMR Biomed; 2004 Nov 10; 17(7):425-6. PubMed ID: 15523700
    [No Abstract] [Full Text] [Related]

  • 19. Imaging the distribution of magnetic nanoparticles with ultrasound.
    Norton SJ, Vo-Dinh T.
    IEEE Trans Med Imaging; 2007 May 10; 26(5):660-5. PubMed ID: 17518060
    [Abstract] [Full Text] [Related]

  • 20. Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging.
    Zhang C, Wängler B, Morgenstern B, Zentgraf H, Eisenhut M, Untenecker H, Krüger R, Huss R, Seliger C, Semmler W, Kiessling F.
    Langmuir; 2007 Jan 30; 23(3):1427-34. PubMed ID: 17241069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.